Tonix Pharmaceuticals Holding (TNXP) Interest Coverage Ratio Growth (3y) (2014 - 2026)
Tonix Pharmaceuticals Holding (TNXP) Interest Coverage Ratio Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 28.11% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.14 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.46 Bn | 37.46 Bn | - | 29.47% |
| 10 | Tonix Pharmaceuticals Holding | 141.18 Mn | 141.18 Mn | 5.30 Mn | -5.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.50% |
| Dec 31, 2025 | 57.03% |
| Sep 30, 2025 | -71.87% |
| Jun 30, 2025 | -207.59% |
| Mar 31, 2025 | 6.79% |
| Dec 31, 2024 | -18.57% |
| Sep 30, 2024 | 55.31% |
| Jun 30, 2024 | 63.14% |
| Mar 31, 2024 | 55.01% |
| Dec 31, 2023 | -34.77% |
| Sep 30, 2023 | 60.48% |
| Jun 30, 2023 | 18.95% |
| Mar 31, 2023 | -57.02% |
| Dec 31, 2022 | -44.66% |
| Sep 30, 2022 | 47.89% |
| Jun 30, 2022 | 71.35% |
| Mar 31, 2022 | -42.71% |
| Dec 31, 2021 | -351.24% |
| Sep 30, 2021 | -62.79% |
| Jun 30, 2021 | -206.97% |